Dr Nick Coatsworth joins GP telehealth company offering compounded semaglutide for weight loss
The former deputy chief medical officer will advise on appropriate clinical governance.
The $100 million GP telehealth corporate Eucalyptus has recruited former deputy chief medical officer Dr Nick Coatsworth as a clinical governance adviser.
The company recently made headlines for prescribing compounded semaglutide amid concerns about the global shortage of Novo Nordisk’s Ozempic.
